한글목차

세계의 수의 CRO 및 CDMO 시장은 2024년에 57억 8,000만 달러로 평가되며, 2030년에는 96억 5,000만 달러에 달하며, CAGR 8.90%로 성장할 것으로 예측됩니다.

이러한 성장의 배경에는 제약회사 및 생명공학 기업이 R&D 및 제조 아웃소싱을 통해 업무 부담을 줄이고 일정을 단축하려는 경향이 강화되고 있는 것이 주요 요인으로 작용하고 있습니다. 동물용 치료제, 백신, 생물제제, 특히 반려동물 및 가축용에 대한 수요 증가로 인해 비용 효율적이고 컴플라이언스를 준수하는 위탁기관의 필요성이 증가하고 있으며, CRO는 임상 및 약사 기능을 지원하고 CDMO는 제제에서 상업적 생산에 이르는 전 영역의 서비스를 제공합니다. 또한 인수공통전염병과 전염병의 위협이 급증하면서 동물 위생 분야의 R&D 투자가 강화되고 전문 아웃소싱 파트너 시장이 확대되고 있습니다. 시장에 영향을 미치는 주요 동향은 CRO, CDMO, 동물용 의약품 개발 기업 간의 전략적 제휴 및 인수합병 증가입니다. 이는 세계 입지를 확대하고 디지털 툴 및 바이오마커 연구와 같은 기술 지원 플랫폼을 임상 연구에 통합해야 할 필요성에 기인합니다.

시장 성장 촉진요인

반려동물 사육 증가와 의료비 지출 증가로 인한 반려동물 양육 증가

주요 시장 이슈

숙련된 수의학 연구 전문가의 한정된 가용성

주요 시장 동향

생물제제 및 첨단 동수처리제에 대한 수요 증가

목차

제1장 개요

제2장 조사 방법

제3장 개요

제4장 고객의 소리

제5장 세계의 수의 CRO 및 CDMO 시장 전망

• 시장 규모·예측
  • 금액별
• 시장 점유율·예측
  • 동물별(반려동물, 가축)
  • 서비스별(발견, 개발, 제조, 포장과 라벨링, 시장 승인과 포스트 마케팅)
  • 용도별(의약품, 생물제제, 의료기기, 기타)
  • 기업별(2024)
  • 지역별
• 시장 맵

제6장 북미의 수의 CRO 및 CDMO 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제7장 유럽의 수의 CRO 및 CDMO 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 수의 CRO 및 CDMO 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 수의 CRO 및 CDMO 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 수의 CRO 및 CDMO 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트

제11장 시장 역학

• 촉진요인
• 과제

제12장 시장 동향과 발전

• 합병과 인수
• 제품 출시
• 최근 동향

제13장 혼란 : 분쟁, 팬데믹, 무역장벽

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• Fortrea Holdings Inc.
• Charles River Laboratories International, Inc.
• Clinvet(Pty) Ltd.
• KLIFOVET GmbH
• Veterinary Research Management, Inc.
• VETSPIN SRL
• Inotiv, Inc.
• IDEXX Laboratories, Inc.
• Vetio Animal Health
• TriRx Pharmaceutical Services, LLC

제16장 전략적 제안

제17장 조사회사 소개·면책사항

영문목차

The Global Veterinary CRO and CDMO Market, valued at USD 5.78 Billion in 2024, is projected to reach USD 9.65 Billion by 2030, growing at a CAGR of 8.90%. This growth is fueled by the increasing tendency of pharmaceutical and biotechnology firms to outsource research, development, and manufacturing to reduce operational loads and accelerate timelines. Rising demand for veterinary therapeutics, vaccines, and biologics-particularly for companion animals and livestock-has amplified the need for cost-efficient and compliant contract organizations. CROs support clinical and regulatory functions, while CDMOs offer full-spectrum services from formulation to commercial manufacturing. Additionally, the surge in zoonotic diseases and infectious threats has intensified R&D investments in animal health, boosting the market for specialized outsourcing partners. A major trend influencing the market is the uptick in strategic collaborations and acquisitions among CROs, CDMOs, and veterinary drug developers, driven by the need to broaden global presence and integrate tech-enabled platforms like digital tools and biomarker studies in clinical research.

Key Market Drivers

Increase in Companion Animal Ownership and Healthcare Spending

The growing number of companion animals and rising expenditure on their healthcare are pivotal factors driving the Veterinary CRO and CDMO market. Increasingly, pets are being viewed as family members, reshaping consumer spending patterns. According to the 2024 Pet Ownership Survey by the American Veterinary Medical Association, 45.5% of U.S. households own dogs and 32.1% own cats-amounting to nearly 90 million dogs and 74 million cats. Annual veterinary spending averages USD 580 per dog and USD 433 per cat. This surge in pet population and associated healthcare costs has led pharmaceutical and biotech companies to expand their veterinary pipelines, thereby increasing the demand for outsourced R&D and manufacturing services.

Key Market Challenges

Limited Availability of Skilled Veterinary Research Professionals

A significant hurdle in the Global Veterinary CRO and CDMO Market is the shortage of skilled veterinary research professionals. Veterinary clinical and preclinical studies require specialized knowledge across diverse species, drug mechanisms, behavioral patterns, and compliance standards. Unlike human trials, veterinary research spans a wide array of animals-companion pets, livestock, equines, and exotic species-each with unique biological needs. This diversity demands expertise in veterinary science, clinical trial methodologies, ethical considerations, and animal care protocols. However, a global shortfall of such multidisciplinary professionals hampers the scalability, timeline adherence, and quality maintenance capabilities of CROs and CDMOs.

Key Market Trends

Increased Demand for Biologics and Advanced Veterinary Therapeutics

The demand for biologics and next-generation veterinary therapeutics is significantly shaping the Veterinary CRO and CDMO market. As animal health issues become more complex, there's a growing preference for high-efficacy biologics like monoclonal antibodies, recombinant proteins, and DNA-based vaccines over traditional small-molecule drugs. These innovative solutions are being developed to address serious conditions such as cancer, autoimmune diseases, and chronic infections in both companion and farm animals. This trend is expanding the need for specialized services from CROs and CDMOs, including immunogenicity evaluations, bioanalytical testing, and biologics manufacturing under high-containment protocols. The advanced infrastructure and analytical capabilities required for biologics are fueling the reliance on expert contract organizations.

Key Market Players

• Fortrea Holdings Inc.
• Charles River Laboratories International, Inc.
• Clinvet (Pty) Ltd.
• KLIFOVET GmbH
• Veterinary Research Management, Inc.
• VETSPIN SRL
• Inotiv, Inc.
• IDEXX Laboratories, Inc.
• Vetio Animal Health
• TriRx Pharmaceutical Services, LLC

Report Scope:

In this report, the Global Veterinary CRO And CDMO Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary CRO And CDMO Market, By Animal:

• Companion Animals
• Livestock Animals

Veterinary CRO And CDMO Market, By Service:

• Discovery
• Development
• Manufacturing
• Packaging & Labeling
• Market Approval & Post Marketing

Veterinary CRO And CDMO Market, By Application:

• Pharmaceuticals
• Biologics
• Medical Devices
• Others

Veterinary CRO And CDMO Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary CRO And CDMO Market.

Available Customizations:

Global Veterinary CRO And CDMO Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Veterinary CRO And CDMO Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal (Companion Animals, Livestock Animals)
  • 5.2.2. By Service (Discovery, Development, Manufacturing, Packaging & Labeling, Market Approval & Post Marketing)
  • 5.2.3. By Application (Pharmaceuticals, Biologics, Medical Devices, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Veterinary CRO And CDMO Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal
  • 6.2.2. By Service
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Veterinary CRO And CDMO Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal
      • 6.3.1.2.2. By Service
      • 6.3.1.2.3. By Application
  • 6.3.2. Mexico Veterinary CRO And CDMO Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal
      • 6.3.2.2.2. By Service
      • 6.3.2.2.3. By Application
  • 6.3.3. Canada Veterinary CRO And CDMO Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal
      • 6.3.3.2.2. By Service
      • 6.3.3.2.3. By Application

7. Europe Veterinary CRO And CDMO Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal
  • 7.2.2. By Service
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Veterinary CRO And CDMO Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal
      • 7.3.1.2.2. By Service
      • 7.3.1.2.3. By Application
  • 7.3.2. Germany Veterinary CRO And CDMO Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal
      • 7.3.2.2.2. By Service
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Veterinary CRO And CDMO Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal
      • 7.3.3.2.2. By Service
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Veterinary CRO And CDMO Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Animal
      • 7.3.4.2.2. By Service
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Veterinary CRO And CDMO Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Animal
      • 7.3.5.2.2. By Service
      • 7.3.5.2.3. By Application

8. Asia-Pacific Veterinary CRO And CDMO Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal
  • 8.2.2. By Service
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Veterinary CRO And CDMO Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal
      • 8.3.1.2.2. By Service
      • 8.3.1.2.3. By Application
  • 8.3.2. India Veterinary CRO And CDMO Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal
      • 8.3.2.2.2. By Service
      • 8.3.2.2.3. By Application
  • 8.3.3. South Korea Veterinary CRO And CDMO Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal
      • 8.3.3.2.2. By Service
      • 8.3.3.2.3. By Application
  • 8.3.4. Japan Veterinary CRO And CDMO Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Animal
      • 8.3.4.2.2. By Service
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Veterinary CRO And CDMO Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Animal
      • 8.3.5.2.2. By Service
      • 8.3.5.2.3. By Application

9. South America Veterinary CRO And CDMO Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal
  • 9.2.2. By Service
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Veterinary CRO And CDMO Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal
      • 9.3.1.2.2. By Service
      • 9.3.1.2.3. By Application
  • 9.3.2. Argentina Veterinary CRO And CDMO Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal
      • 9.3.2.2.2. By Service
      • 9.3.2.2.3. By Application
  • 9.3.3. Colombia Veterinary CRO And CDMO Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal
      • 9.3.3.2.2. By Service
      • 9.3.3.2.3. By Application

10. Middle East and Africa Veterinary CRO And CDMO Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Animal
  • 10.2.2. By Service
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Veterinary CRO And CDMO Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Animal
      • 10.3.1.2.2. By Service
      • 10.3.1.2.3. By Application
  • 10.3.2. Saudi Arabia Veterinary CRO And CDMO Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Animal
      • 10.3.2.2.2. By Service
      • 10.3.2.2.3. By Application
  • 10.3.3. UAE Veterinary CRO And CDMO Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Animal
      • 10.3.3.2.2. By Service
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Fortrea Holdings Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Charles River Laboratories International, Inc.
• 15.3. Clinvet (Pty) Ltd.
• 15.4. KLIFOVET GmbH
• 15.5. Veterinary Research Management, Inc.
• 15.6. VETSPIN SRL
• 15.7. Inotiv, Inc.
• 15.8. IDEXX Laboratories, Inc.
• 15.9. Vetio Animal Health
• 15.10. TriRx Pharmaceutical Services, LLC

16. Strategic Recommendations

17. About Us & Disclaimer